The Cigna Group Reports Strong Third Quarter 2024 Results, Reaffirms 2024 Adjusted EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CIGNA (CI) PT Raised to $394 at Piper Sandler
November 4, 2024 4:04 PM ESTPiper Sandler analyst Jessica Tassan raised the price target on CIGNA (NYSE: CI) to $394.00 (from $392.00) while maintaining a Overweight rating.
The analyst comments "CI reported a pharmacy-led 3Q24 adjusted EPS beat and reiterated adjusted CY24 guidance. Notwithstanding the asset sale at Cigna Healthcare and... More
CIGNA (CI) PT Lowered to $406 at Jefferies
November 1, 2024 5:45 AM EDTJefferies analyst David Windley lowered the price target on CIGNA (NYSE: CI) to $406.00 (from $422.00) while maintaining a Buy rating.
The analyst comments "To our ears, the response to HUM headlines has been consistent (on our Sept NDR and the call): not... More
